Unlock next generation heparin-based therapeutics with IntelliHep

We're untapping the potential of heparin-based therapeutics in biomedical applications including neurodegeneration and cancer. Our compounds have further potential applications in inflammation, angiogenesis, wound healing, regenerative medicine and infectious diseases.


IntelliHep is exploiting a technology platform to generate novel heparin-based chemical entities, and also pursuing in-house pre-clinical development of lead candidates.

Find out more


Our team have over 70 years of complementary expertise between them in heparin glycobiology, heparin chemistry, sugar analysis and purification, protein/carbohydrate interactions and screening.

Find out more

R&D Portfolio

Our R&D portfolio spans generation of novel heparin-based compounds for both in-house and collaborative studies, and developing lead candidates for Alzheimers disease and cancer.

Find out more